Episode
How Your Body Data Could Reshape Sectors
- Podcast
- Thoughts on the Market
- Published
- May 12, 2026
- Duration seconds
- 309
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/thoughts-on-the-market-980853/episodes/how-your-body-data-could-reshape-sectors/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/thoughts-on-the-market-980853/how-your-body-data-could-reshape-sectors.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Our U.S. Healthcare Analyst Erin Wright discusses how health tracking and preventive diagnostics could influence healthcare costs and different industries, from fitness to retail. Read more insights from Morgan Stanley. ----- Transcript ----- Welcome to Thoughts on the Market. I’m Erin Wright, Morgan Stanley’s U.S. Healthcare Services Analyst. Today – the emergence of the self-directed patient and its implications. It’s Tuesday, May 12th at 10am in New York. A blood test ordered from your phone. A wearable that tracks your sleep or nudges you to move, recover, hydrate, or rethink last night’s dinner. Preventive health is moving out of the clinic and into everyday life. And that shift is becoming an investable theme. In essence, healthcare is moving from reactive to proactive. Instead of waiting for symptoms, more consumers are using lab tests, wearables, imaging, and digital tools to spot some these risks earlier. And this shift reaches well beyond healthcare. On our estimates, the U.S. spends about [$]3.4 trillion annually on chronic diseases, including lost economic productivity. About [$]1.4 trillion of 2024 spend was tied to preventable disease. So the big investment question is: can earlier detection and behavior change bend the cost curve? We think expanded preventive testing, screening, and monitoring can help avoid roughly [$]200 billion to [$]800 billion of U.S. healthcare spend by 2050. That assumes preventive testing reduces preventable disease costs by about 10% to 30% based on our analysis. Direct-to-consumer lab testing lets people order lab tests directly, often online, without starting with a traditional doctor visit. We see this as a roughly $4 billion U.S. market, which has more than doubled since…